HSBC Holdings’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $124K | Buy |
|
|||||
|
2025
Q2 | $77K | Sell |
|
|||||
|
2025
Q1 | $94.8K | Buy |
|
|||||
|
2024
Q4 | $90.7K | Sell |
|
|||||
|
2024
Q3 | $166K | Sell |
|
|||||
|
2024
Q2 | $226K | Sell |
|
|||||
|
2024
Q1 | $356K | Sell |
|
|||||
|
2023
Q4 | $251K | Buy |
|
|||||
|
2023
Q3 | $115K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $324K | Buy |
|
|||||
|
2022
Q3 | $302K | Sell |
|
|||||
|
2022
Q2 | $950K | Sell |
|
|||||
|
2022
Q1 | $1.47M | Buy |
|
|||||
|
2021
Q4 | $1.25M | Buy |
|
|||||
|
2021
Q3 | $681K | Sell |
|
|||||
|
2021
Q2 | $529K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $218K | Buy |
|
|||||
|
2020
Q3 | $238K | Sell |
|
|||||
|
2020
Q2 | $1.02M | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $914K | Buy |
|